Skip to content
mapperlab
← Dashboard
Stock

ADAPY

ADAPTIMMUNE THERAPEUTICS PLC
Latest close $0.020 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
0
27 funds tracked
Ever held
4
Current + past
New this quarter
0
Exited this quarter
0

Marquee-fund ownership over time

Aug 9, 2024Nov 14, 2024May 15, 2025Feb 12, 2026
Now
0

Past holders

Funds that exited at some point
FundEntry → ExitReturn
Renaissance Technologies→ $0.03-97%
Two Sigma Investments→ $0.07-88%
Millennium Management→ $0.07-93%
Citadel Advisors 2× in & out→ $0.26-54%

Trade history

Every open→close lifecycle across tracked funds
FundOpen dateClose dateOpen priceClose price / currentReturn
Citadel AdvisorsQ1 2025Q2 2025$0.58$0.26-54%
Two Sigma InvestmentsQ4 2024Q3 2025$0.59$0.07-88%
Citadel AdvisorsQ3 2024Q4 2024$1.04$0.59-43%
Millennium ManagementQ3 2024Q3 2025$1.04$0.07-93%
Renaissance TechnologiesQ3 2024Q1 2026$0.99$0.03-97%
Caveats
  • Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
  • Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
  • “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
  • Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
  • Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.